Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Jun
7
2023
GAO’s Priority Open Recommendations for EPA Include Recommendations Regarding the IRIS Program Bergeson & Campbell, P.C.
Jun
7
2023
The More You Claim, The More You Must Enable: SCOTUS Delivers Amgen v. Sanofi Opinion Dinsmore & Shohl LLP
Jun
7
2023
Supreme Court Again Tightens FCA Intent, But Tricky Questions Linger ArentFox Schiff LLP
Jun
7
2023
Bipartisan Lawmakers Seek to Remove Tariffs on Infant Formula with Proposed Formula 3.0 Act Keller and Heckman LLP
Jun
7
2023
FDA Requests Public Input on Increasing Access to Home-Use Health Technologies Mintz
Jun
7
2023
From Farm to Table: How the Supreme Court’s Pork Ruling Impacts States’ Rights and Doing Business in California Squire Patton Boggs (US) LLP
Jun
6
2023
HSE Proposes to Include Substances in UK REACH Substance Evaluation Rolling Action Plan Bergeson & Campbell, P.C.
Jun
6
2023
FDA’s New Dietary Supplement Ingredient Directory
Jun
6
2023
FDA Clarifies Approach to Pediatric Drug Development Sheppard, Mullin, Richter & Hampton LLP
Jun
6
2023
FDA Issues Final Guidance for Inorganic Arsenic in Apple Juice Keller and Heckman LLP
Jun
6
2023
Telehealth Flexibilities Continue After End of COVID-19 Emergency ArentFox Schiff LLP
Jun
6
2023
ClientEarth Litigation in U.S. Over Deforestation in Brazil Cadwalader, Wickersham & Taft LLP
Jun
5
2023
FDA Webinar Reiterates a New Regulatory Pathway Created by Federal Legislation is Required for CBD Keller and Heckman LLP
Jun
5
2023
Certain Employers in Ontario Are Now Required to Have Naloxone Kits At Their Workplace Mintz
Jun
4
2023
Highlights for Research Institutions and Sponsors in FDA's Recent Draft Guidance on Decentralized Clinical Trials K&L Gates LLP
Jun
4
2023
Unanimous Supreme Court Endorses Subjective Belief Standard for False Claims Liability Robinson & Cole LLP
Jun
4
2023
Minnesota Legalizes Recreational Marijuana, Protects Off-Duty Use Jackson Lewis P.C.
Jun
4
2023
FDA Cracking Down on Unapproved HCT/Ps with Fourth Untitled Letter of 2023 Sheppard, Mullin, Richter & Hampton LLP
Jun
3
2023
Wisconsin Supreme Court Affirms Court of Appeals Decision that Anti-Assignment Clause Does Not Prohibit Post-Loss Assignment of Insurance Rights von Briesen & Roper, s.c.
Jun
3
2023
EPA Completes Verification Analysis of PFAS Scientific Testing of Pesticide Products Bergeson & Campbell, P.C.
Jun
2
2023
U.S. Workforce Positive Post-Accident Marijuana Drug Test Rates Reach Twenty-Five Year High Jackson Lewis P.C.
Jun
2
2023
Israel Approves the First Animal-Free Protein for Food Use Keller and Heckman LLP
Jun
2
2023
MCDERMOTTPLUS CHECK-UP: JUNE 2, 2023 McDermott Will & Emery
Jun
1
2023
SCCS Updates Guidance for the Testing of Cosmetic Ingredients and Their Safety Evaluation Bergeson & Campbell, P.C.
Jun
1
2023
Unpacking Averages: Understanding the Potential for Bias in a Sepsis Prediction Algorithm, a Case Study Epstein Becker & Green, P.C.
Jun
1
2023
CMS Proposing Major Changes to Medicaid Drug Rebate Program Blank Rome LLP
Jun
1
2023
EPA Issues Final Rule to Accelerate Use of Plant-Incorporated Biotechnologies Bergeson & Campbell, P.C.
Jun
1
2023
Marketing Implications of California’s Proposition 12 Keller and Heckman LLP
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters